|
US2021087603A1
|
|
Methods, kits and devices for measuring extracellular pyridine nucleotide
|
|
WO2020188018A1
|
|
Microscopy system for oblique plane microscopy
|
|
WO2020127815A1
|
|
Method for preserving urinary cells
|
|
EP3808381A1
|
|
Iron (iii) complexes with novel contrast properties for magnetic resonance imaging
|
|
DE102019124017A1
|
|
Device and method for UV antiseptics
|
|
EP3769761A1
|
|
Cxcr4 antagonists for treatment of cardiovascular conditions
|
|
DE102019109524A1
|
|
Calcium coacervates for remineralization and demineralization inhibition
|
|
WO2019180243A1
|
|
Crispr associated protein reactive t cell immunity
|
|
CA3090966A1
|
|
Mc4r agonist efficacy in subjects with mc4r deficiencies and impaired nfat signaling
|
|
EP3755817A1
|
|
Method for determining dermatophytes
|
|
EP3683229A1
|
|
Specific t cell receptors against epitopes of mutant myd88l265p protein for adoptive t cell therapy
|
|
EP3666940A1
|
|
Method of producing poly(alkyl cyanoacrylate) based nano/microfibers and uses thereof
|
|
EP3633604A1
|
|
Method for automatic shape quantification of an optic nerve head
|
|
US2019100727A1
|
|
Cells for Therapy of the Heart
|
|
US2020197341A1
|
|
Immunmodulation for prevention of poor healing of musculoskeletal injuries in compromised patients
|
|
US2020170503A1
|
|
Method for estimating shape parameters of the fovea by optical coherence tomography
|
|
EP3591614A1
|
|
Method and computer program for segmentation of optical coherence tomography images of the retina
|
|
EP3586878A1
|
|
Method for producing a fe tcdta contrast agent and product obtainable according to the method
|
|
WO2018234549A1
|
|
Bodytime - a new diagnostic tool to assess the internal clock
|
|
WO2018234472A1
|
|
System, method, and computer program product for determining cortical bone characteristics
|
